February 18, 2021
The vaccine was recently approved by the WHO for emergency use.
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the Oxford/AstraZeneca COVID-19 vaccine for use in Nigeria.
The Director-General of NAFDAC, Dr. Mojisola Adeyeye, disclosed this on Thursday.
Image
The vaccine was recently approved by the WHO for emergency use.
Adeyeye said NAFDAC got the dossier of the vaccine a week ago, and its safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine.